Agriculture committee  I think a good example is corn. In corn, variety registration ceased several years ago, probably about 10 years ago. We aren't registering varieties. The school of thought there was that companies are going to be motivated to bring out better varieties; if they brought out a lesser variety, they wouldn't last very long.

Agriculture committee  I think the way Monsanto looks at it is that we create the data, but we don't write the test. There are certain things we need to deliver up to get regulatory approval. We don't get to decide what we submit, but we do have to submit a robust data package for all the technologies we propose be advanced.

Agriculture committee  Thanks, Mr. Chair. I bring the perspective of a decreasing demographic—those who have lived pre-biotech and post-biotech. There are fewer and fewer people who have been able to see the pre-biotech era and the post-biotech era. I can comment on both. One of the biggest advantages we've seen in the biotech on growers is that growers work in an environment where there is total risk—weather, crop prices, and other risks—in an uncertain environment.